Analyzing...
Loading company...
TCM Ltd. engages in the business of manufacturing chemicals products, agribusiness, metals & minerals and constructions & developments. The company is headquartered in Kochi, Kerala. The firm's segments include Solar Division, Sale of Auto care Products and Sale of Healthcare Devices. The Company, through its subsidiary TCM Healthcare Private Limited, is in the business of manufacturing, buying, selling, importing, exporting of SARS-CoV-2 test kits. The company also deals in all types of medical devices, surgical, medical, dental and scientific equipment, instruments and accessories, sanitizer, mask, PPE kit, apparatus, machineries, fittings, components and accessories used in health care, treatment, diagnosis, research test cure, disposable medical and surgical instruments and consumables and other allied products. Its subsidiaries include iSpark Learning Solutions Pvt Ltd and TCM Healthcare Private Limited.
Excluded by gate
No significant concerns identified
Nothing flagged for monitoring
“Operates in Chemicals — Specialty & Commodity.”
₹20 Cr revenue.
COGS 72.4%, employees 24.7%.
| KPI | Company | Sector Median |
|---|---|---|
| ROE | -23.5%▼ | 7.7% |
| ROCE | -12.6%▼ | 10.8% |
| Net Margin | -28.1%▼ | 5.1% |
| EBITDA Margin | -17.1%▼ | 11.1% |
| Debt To Equity | 0.90x▲ | 0.18x |
| Rev Growth 3yr | 41.1%▲ | 2.0% |
| EPS Growth 3yr | 13.3%▲ | -1.3% |
Historical valuation data not available.
| (₹ Cr) | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|---|
| Revenue | ₹20 Cr -24.1% | ₹26 Cr -19.3% | ₹32 Cr +338.7% | ₹7 Cr +106.7% | ₹4 Cr -16.4% | ₹4 Cr +361.8% | ₹0.92 Cr |
| Other Income | ₹0.96 Cr -78.5% | ₹4 Cr +936.2% | ₹0.43 Cr | ₹0.02 Cr -97.5% | ₹0.89 Cr -28.3% | ₹1 Cr +7.5% | ₹1 Cr |
| Total Income | ₹21 Cr -32.1% | ₹30 Cr -6.7% | ₹33 Cr +343.2% | ₹7 Cr +66.0% | ₹4 Cr -19.1% | ₹5 Cr +165.1% | ₹2 Cr |
| COGS | ₹14 Cr -21.4% | ₹18 Cr -21.8% | ₹23 Cr +300.6% | ₹6 Cr +144.8% | ₹2 Cr +26.3% | ₹2 Cr +187.6% | ₹0.65 Cr |
| ₹27 Cr -8.2% | ₹29 Cr -16.6% | ₹35 Cr +199.3% | ₹12 Cr +50.6% | ₹8 Cr +49.6% | ₹5 Cr +193.5% | ₹2 Cr | |
| Profit Before Tax | (₹6 Cr) ↓ Decline | ₹1 Cr ↑ Recovery | (₹2 Cr) +47.6% | (₹4 Cr) -30.0% | (₹3 Cr) ↓ Decline | ₹0.31 Cr +0.8% | ₹0.30 Cr |
| (₹0.04 Cr) -10.6% | (₹0.03 Cr) ↓ Decline | ₹0.04 Cr ↑ Recovery | (₹0.02 Cr) | (₹0.00 Cr) ↓ Decline | ₹0.19 Cr | ₹0.00 Cr | |
| Net Profit | (₹6 Cr) ↓ Decline | ₹1 Cr ↑ Recovery | (₹2 Cr) +46.4% | (₹4 Cr) -29.4% | (₹3 Cr) ↓ Decline | ₹0.12 Cr -61.2% | ₹0.30 Cr |
| Profit (Owners) | (₹6 Cr) ↓ Decline | ₹2 Cr ↑ Recovery | (₹2 Cr) +51.3% | (₹4 Cr) -21.3% | (₹3 Cr) ↓ Decline | ₹0.12 Cr -61.2% | ₹0.30 Cr |
| Minority Interest | (₹0.18 Cr) +17.0% | (₹0.21 Cr) +37.3% | (₹0.34 Cr) -26.9% | (₹0.27 Cr) | ₹0.00 Cr | ₹0.00 Cr | ₹0.00 Cr |
| Other Comprehensive Income | (₹0.01 Cr) ↓ Decline | ₹0.11 Cr | ₹0.00 Cr | ₹0.00 Cr | ₹0.00 Cr | ₹0.00 Cr +100.0% | (₹0.25 Cr) |
| EPS | (₹7.78) | ₹2.16 | (₹2.61) | (₹5.35) | (₹4.41) | ₹0.16 | ₹0.41 |
| Diluted Shares | ₹0.75 Cr | ₹0.75 Cr | ₹0.75 Cr | ₹0.75 Cr | ₹0.75 Cr | ₹0.75 Cr | ₹0.75 Cr |
No related party data available for this company.
This section will be populated when data becomes available.
No earnings call transcripts available.
Pursuant to Regulation 24A of SEBI (LODR) Regulations 2015, we are enclosing herewith the Annual Secretarial Compliance Report of the Company for the year ended 31st March 2026 issued by .... Pursuant...
Pursuant to Regulations 30 and 47 of SEBI(LODR) Regulations, 2015, we are forwarding herewith copies of Newspaper clippings regarding Audited Consolidated & Standalone Financial Results .... Pursuant ...
The Board of Directors of the Company in its meeting held on Tuesday, 26th May, 2026 has considered and approved the following business:- 1. Audited Standalone and Consolidated Financial .... The Boa...
In accordance with the provisions of the SEBI(LODR)Regulations 2015 and with reference to the Corporate announcement dated 17th September 2025, the order stands cancelled . The details .... In accor...
With reference to the above, please find enclosed herewith the Disclosure / Declaration under Regulation 31(4) of SEBI(SAST) Regulations 2011 received from the Promoters of the Company-Mr. .... With r...
<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=''1px''><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</...
We are hereby enclosing a Confirmation Certificate under Regulation 74(5) of SEBI(DP) Regulations 2018 for the quarter ending 31st March 2026 received from our RTA, M/s Cameo Corporate .... We are her...
In compliance of SEBI(Prohibition of Insider Trading) Regulations, 2015 read with amendments thereto and further clarification given by BSE vide its letter dated 02nd April 2019 vide Ref .... In compl...
Disclaimer · The Stock Filter is an information platform, not a SEBI-registered investment adviser. All data, scores, and narratives are generated from public filings and AI analysis — they do not constitute investment advice, recommendations, or endorsements. Always consult a qualified financial adviser before making investment decisions. Past performance does not guarantee future results.
No dividend history available for this company.